Dr. Sarper Tanli
Dr. Sarper Tanli is a seasoned professional in healthcare development and management, boasting substantial expertise in the Middle East, particularly in the UAE. His extensive background covers healthcare planning, development, clinical operations, digital health services, and informatics on a global scale. Since his arrival in the UAE in 2004, Dr. Tanli has actively participated in diverse and impactful startup ventures, encompassing hospitals, wellness centers, and outpatient facilities. His roles have spanned from senior executive positions to lead consultancy engagements.
Notably, he contributed significantly to Harvard Medical International (HMI) and played a pivotal role in the strategic planning and advancement of Dubai Health Care City (DHCC). Dr. Tanli led multiple projects within DHCC, including the formulation of the master clinical plan, the establishment of licensing structures (CPQ), the design of governance models, and the development of a 500-bed teaching hospital. An innovative achievement was the creation of the pioneering Integrated Health Data Network, known as HIRAS. Additionally, he spearheaded the formulation of initial regulations governing alternative and complementary medicine practices in the UAE, operating under DHCC's legal framework.
Subsequent to his tenure at DHCC, he took on the responsibility of guiding Houston Methodist Global Health Care Services. Over eight years in the capacity of Vice President, Dr. Tanli excelled in advisory roles, hospital management, and training/education programs. His role was marked by forging numerous partnerships across Europe, the Middle East, and Africa, working with conglomerate clients to conceptualize and execute projects. His influence extended to overseeing the establishment and operational aspects of healthcare initiatives for prominent companies such as Emaar and Meraas. Dr. Tanli's purview encompassed the development of clinical, operational, and quality programs, culminating in successful operationalization.
A visionary leader, he introduced the first-of-its-kind integrative medicine approach, seamlessly integrating alternative/complementary medicine services with conventional healthcare at Dubai Mall Medical Center, opened in 2009. His contributions also extended to establishing the Center for Outcomes Research and Education (CORE) at Houston Methodist, with multiple copyrights attributed to the utilization of clinical pathways in hospital settings. During his tenure as Global Vice President at Houston Methodist, he provided consultancy to a significant radiation oncology and diagnostic center in Eastern Europe. Moreover, he played a pivotal role in spearheading various market studies, strategic plans, business plans, and feasibility studies for healthcare projects across the Middle East and Africa.
For four years until June 2020, Dr. Tanli held the esteemed position of Group Chief Executive Officer at Manzil Healthcare Services, a home health service company. During this tenure, he not only oversaw regional expansion but also orchestrated the transformation of the company into a digital health enterprise, with a particular focus on disease management and medicalized home health and wellness services. Beyond this, he founded several health tech and services companies, including Diginova Health Solutions, which played a pivotal role in expanding and implementing globally recognized digital health solutions in the GCC region. Other ventures include MINTEA, a mental health platform, and Vita Healthcare, a company dedicated to enhancing the quality of life for the elderly. Dr. Tanli's involvement extends to serving as an external independent board member for two hospitals in KSA and a diabetes management company in the UAE.
Presently, he holds the esteemed position of Managing Director at Mass General Brigham for the Middle East & Africa. Mass General Brigham, as the teaching hospitals group for Harvard Medical School, is renowned for its extensive outreach and advisory programs globally, spanning service development, academic initiatives, and research support.